Drug Testing

Drugs-of-abuse testing products receive FDA clearance

Published in Medical Letter on the CDC and FDA, March 7th, 2004

Varian, Inc., (VARI) announced that two of its latest rapid drugs-of-abuse testing products - OnTrak TesTcup II and OnSite CupKit - have received 510(k) clearance from the U.S. Food and Drug Administration (FDA), enabling the company to sell to customers requiring or requesting FDA clearance.

FDA clearance is required before a company can bring a medical device or product to market. In addition to OnTrak TesTcup II and OnSite CupKit receiving FDA clearance, all of Varian, Inc.'s urine-based rapid drugs-of-abuse testing products have 510(k) status, including the current market-leading OnTrak TesTcup and OnTrak TesTstik product lines.

The OnSite CupKit...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-03-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry